Therapies used for the management of myofascial temporomandibular disorders: bibliometric analysis
Terapias utilizadas para o manejo da disfunção temporomandibular de origem miofascial: análise bibliométrica
Jessica Fernanda Lima Batista; Laércio Guedes de Lima Júnior; Sérgio Soares da Silva; Marcela Carla Nascimento; Miguel Meira e Cruz; Mônica Vilela Heimer
Abstract
Keywords
Resumo
JUSTIFICATIVA E OBJETIVOS: Disfunção temporomandibular (DTM) é um termo utilizado para descrever um conjunto de condições dolorosas e funcionais que podem afetar a articulação temporomandibular (ATM), os músculos mastigatórios e/ou suas estruturas associadas. Para DTM miofascial, terapias conservadoras, incluindo fármacos (analgésicos e/ou anti-inflamatórios), fisioterapia, placa oclusal e autogestão da dor apresentam os melhores benefícios para o paciente. O objetivo deste estudo foi abordar, através de uma análise bibliométrica, o conhecimento existente sobre os tratamentos utilizados na DTM de origem miofascial.
CONTEÚDO: A busca foi realizada na base de dados Web of Science (WOS) e SCOPUS, em julho e atualização em dezembro de 2023, por meio dos descritores do MeSh “Temporomandibular Joint Dysfunction Syndrome” e “Therapeutics”. Além disso, um mapeamento bibliométrico foi realizado no software VOSviewer. Para análise, foram incluídos dados sobre os termos do título e do resumo, tipo de documento, número de citações, nome dos periódicos, artigo mais citado e ano de publicação e, além destes, o país do autor correspondente, tipo de tratamento, tipo de estudo e resultados. Dos 760 artigos identificados, 63 foram selecionados para compor esta revisão. Destes, a maioria era artigos originais, ensaios clínicos e foram publicados em 2012. Os tratamentos mais frequentes foram: placa oclusal, laser, terapia manual, toxina botulínica e agulhamento a seco. Dos 15 países analisados, o Brasil foi o país com maior número de publicações.
CONCLUSÃO: Houve um aumento de artigos sobre a temática publicados, sendo o Brasil o país com mais publicações e os tratamentos mais utilizados foram placa oclusal e laser.
Palavras-chave
Referências
1 What is orofacial pain? American Academy of Orofacial Pain. 2015 [cited 2015 April, 16]. Available from:
2 Chantaracherd P, John MT, Hodges JS, Schiffman EL. Temporomandibular joint disorders’ impact on pain, function, and disability. J Dent Res. 2015;94(3 Suppl):79S-86S.
3 Bilici IŞ, Emes Y, Aybar B, Yalçın S. Evaluation of the effects of occlusal splint, trigger point injection and arthrocentesis in the treatment of internal derangement patients with myofascial pain disorders. J Craniomaxillofac Surg. 2018;46(6):916-22.
4 Pihut ME, Margielewicz J, Kijak E, Wiśniewska G. Evaluation of articular disc loading in the temporomandibular joints after prosthetic and pharmacological treatment in model studies. Adv Clin Exp Med. 2017;26(3):455-60.
5 Ohrbach R. Editor. Diagnostic Criteria for Temporomandibular Disorders: Assessment Instruments. Version15May2016. [Critérios de Diagnóstico para Desordens Temporomandibulares: Protocolo Clínico e Instrumentos de Avaliação: Brazilian Portuguese Version 25May2016] Pereira Jr FJ, Gonçalves DAG, Trans.
6 Deregibus A, Ferrillo M, Grazia Piancino M, Chiara Domini M, de Sire A, Castroflorio T. Are occlusal splints effective in reducing myofascial pain in patients with muscle-related temporomandibular disorders? A randomized-controlled trial. Turk J Phys Med Rehabil. 2021;67(1):32-40.
7 Fleckenstein J, Zaps D, Rüger LJ, Lehmeyer L, Freiberg F, Lang PM, Irnich D. Discrepancy between prevalence and perceived effectiveness of treatment methods in myofascial pain syndrome: results of a cross-sectional, nationwide survey. BMC Musculoskelet Disord. 2010;11:32.
8 Gerber LH, Sikdar S, Armstrong K, Diao G, Heimur J, Kopecky J, Turo D, Otto P, Gebreab T, Shah J. A systematic comparison between subjects with no pain and pain associated with active myofascial trigger points. PM R. 2013;5(11):931-8.
9 Pastore GP, Goulart DR, Pastore PR, Prati AJ, de Moraes M. Self-medication among myofascial pain patients: a preliminary study. Open Dent J. 2018;12:347-53.
10 de Melo LA, Bezerra de Medeiros AK, Campos MFTP, Bastos Machado de Resende CM, Barbosa GAS, de Almeida EO. Manual therapy in the treatment of myofascial pain related to temporomandibular disorders: a systematic review. J Oral Facial Pain Headache. 2020;34(2):141-8.
11 Christidis N, Ndanshau EL, Sandberg A, Tsilingaridis G. Prevalence and treatment strategies regarding temporomandibular disorders in children and adolescents-A systematic review. J Oral Rehabil. 2019;46(3):291-301.
12 Sobral APT, Godoy CLH, Fernandes KPS, Bussadori SK, Ferrari RAM, Horliana ACRT, Monken S F, Motta LJ. Photomodulation in the treatment of chronic pain in patients with temporomandibular disorder: protocol for cost-effectiveness analysis. BMJ Open. 2018;8(5):e018326.
13 Stechman-Neto J, Porporatti AL, Porto de Toledo I, Costa YM, Conti PC, De Luca Canto G, Mezzomo LA. Effect of temporomandibular disorder therapy on otologic signs and symptoms: a systematic review. J Oral Rehabil. 2016;43(6):468-79.
14 Bai B, Bai X, Wang C. Mapping research trends of temporomandibular disorders from 2010 to 2019: A bibliometric analysis. J Oral Rehabil. 2021;48(5):517-30.
15 Kuzmanovic Pficer J, Dodic S, Lazic V, Trajkovic G, Milic N, Milicic B. Occlusal stabilization splint for patients with temporomandibular disorders: Meta-analysis of short and long term effects. PLoS One. 2017;12(2):e0171296.
16 Al-Moraissi EA, Farea R, Qasem KA, Al-Wadeai MS, Al-Sabahi ME, Al-Iryani GM. Effectiveness of occlusal splint therapy in the management of temporomandibular disorders: network meta-analysis of randomized controlled trials. Int J Oral Maxillofac Surg. 2020;49(8):1042-56.
17 Machado D, Martimbianco ALC, Bussadori SK, Pacheco RL, Riera R, Santos EM. Botulinum toxin type a for painful temporomandibular disorders: systematic review and meta-analysis. J Pain. 2020;21(3-4):281-93.
18 Keskin Tunç S, Ünalan Değirmenci B, Alpaslan Yaylı N, Aslan Ş, Akdeniz MŞ. Evaluation the effects of low-level laser therapy on disc displacement with reduction. Turk J Phys Med Rehabil. 2020;66(1):24-30.
19 Aksu Ö, Pekin Doğan Y, Sayıner Çağlar N, Şener BM. Comparison of the efficacy of dry needling and trigger point injections with exercise in temporomandibular myofascial pain treatment. Turk J Phys Med Rehabil. 2019;65(3):228-35.
20 Zhang J, Xie J, Hou W, Tu X, Xu J, Song F, Wang Z, Lu Z. Mapping the knowledge structure of research on patient adherence: knowledge domain visualization-based co-word analysis and social network analysis. PLoS One. 2012;7(4):e34497.
21 Turk DC, Zaki HS, Rudy TE. Effects of intraoral appliance and biofeedback/stress management alone and in combination in treating pain and depression in patients with temporomandibular disorders. J Prosthet Dent. 1993;70(2):158-64.
22 Wright WH. Deafness as influenced by malposition of the Jaws. J Nat Dental Assoc. 1920;7(12):979-92.
23 Dworkin SF, Turner JA, Wilson L, Massoth D, Whitney C, Huggins KH, Burgess J, Sommers E, Truelove E. Brief group cognitive-behavioral intervention for temporomandibular disorders. Pain. 1994;59(2):175-87.
24 de Lucena LB, Kosminsky M, da Costa LJ, de Góes PS. Validation of the Portuguese version of the RDC/TMD Axis II questionnaire. Braz Oral Res. 2006;20(4):312-7.
25 Schiffman E, Ohrbach R. Executive summary of the Diagnostic Criteria for Temporomandibular Disorders for clinical and research applications. J Am Dent Assoc. 2016;147(6):438-45.
26 Melo RA, de Resende CMBM, Rêgo CRF, Bispo ASL, Barbosa GAS, de Almeida EO. Conservative therapies to treat pain and anxiety associated with temporomandibular disorders: a randomized clinical trial. Int Dent J. 2020;70(4):245-53.
27 Guarda-Nardini L, Stecco A, Stecco C, Masiero S, Manfredini D. Myofascial pain of the jaw muscles: comparison of short-term effectiveness of botulinum toxin injections and fascial manipulation technique. Cranio. 2012;30(2):95-102.
28 Yao L, Sadeghirad B, Li M, Li J, Wang Q, Crandon HN, Martin G, Morgan R, Florez ID, Hunskaar BS, Wells J, Moradi S, Zhu Y, Ahmed MM, Gao Y, Cao L, Yang K, Tian J, Li J, Zhong L, Couban RJ, Guyatt GH, Agoritsas T, Busse JW. Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials. BMJ. 2023;383:e076226. Erratum in: BMJ. 2024;384:q253.
29 Michelotti A, Parisini F, Farella M, Cimino R, Martina R. Fisioterapia muscolare in pazienti con disordini temporomandibolari. Studio clinico controllato [Muscular physiotherapy in patients with temporomandibular disorders. Controlled clinical trial]. Minerva Stomatol. 2000;49(11-12):541-8.
30 Kalamir A, Pollard H, Vitiello A, Bonello R. Intra-oral myofascial therapy for chronic myogenous temporomandibular disorders: a randomized, controlled pilot study. J Man Manip Ther. 2010;18(3):139-46.
31 Kalamir A, Graham PL, Vitiello AL, Bonello R, Pollard H. Intra-oral myofascial therapy versus education and self-care in the treatment of chronic, myogenous temporomandibular disorder: a randomised, clinical trial. Chiropr Man Therap. 2013;21:17.
32 de Freitas R F, Ferreira MÂ, Barbosa GA, Calderon PS. Counselling and self-management therapies for temporomandibular disorders: a systematic review. J Oral Rehabil. 2013;40(11):864-74.
33 Öz S, Gökçen-Röhlig B, Saruhanoglu A, Tuncer EB. Management of myofascial pain: low-level laser therapy versus occlusal splints. J Craniofac Surg. 2010;21(6):1722-8.
34 Batista, JFOL, Vila-Noca, TEL, Moraes, SLD, Pellizzer, E P, Vasconcelos, BCE, Gomes, JML, Lemos, CAA, Heimer, MV. Are exercises with or without occlusal splints more effective in the reduction of pain in patients with temporomandibular disorders of myogenic origin? A systematic review. J. Appl. Oral Sci. 2022;30:e20220298.
35 Qvintus V, Suominen AL, Huttunen J, Raustia A, Ylöstalo P, Sipilä K. Efficacy of stabilisation splint treatment on facial pain - 1-year follow-up. J Oral Rehabil. 2015;42(6):439-46.
36 Tripathi P, Mathur H, Tripathi S, Saxena VS, Ahmed J. Miseries and remedies of myofascial pain dysfunction syndrome: Comparative study. J Indian Acad Oral Med Radiol. 2019;31:210-6.
37 Fricton JR. Etiology and management of masticatory myofascial pain. J Musculoskeletal Pain. 1999;7(1-2):143-60.
38 Alencar F Jr, Becker A. Evaluation of different occlusal splints and counselling in the management of myofascial pain dysfunction. J Oral Rehabil. 2009;36(2):79-85.
39 Ekberg E, Nilner M. Treatment outcome of appliance therapy in temporomandibular disorder patients with myofascial pain after 6 and 12 months. Acta Odontol Scand. 2004;62(6):343-9.
40 Pessoa DR, Costa DR, Prianti BM, Costa DR, Delpasso CA, Arisawa EÂLS, Nicolau RA. Association of facial massage, dry needling, and laser therapy in Temporomandibular Disorder: case report. Codas. 2018;30(6):e20170265.
41 Seifi M, Ebadifar A, Kabiri S, Badiee MR, Abdolazimi Z, Amdjadi P. Comparative effectiveness of low level laser therapy and transcutaneous electric nerve stimulation on temporomandibular joint disorders. J Lasers Med Sci. 2017;8(Suppl 1):S27-S31.
42 Magri LV, Carvalho VA, Rodrigues FC, Bataglion C, Leite-Panissi CR. Effectiveness of low-level laser therapy on pain intensity, pressure pain threshold, and SF-MPQ indexes of women with myofascial pain. Lasers Med Sci. 2017;32(2):419-28.
43 Santos Tde S, Piva MR, Ribeiro MH, Antunes AA, Melo AR, Silva ED. Lasertherapy efficacy in temporomandibular disorders: control study. Braz J Otorhinolaryngol. 2010;76(3):294-9.
44 Shirani AM, Gutknecht N, Taghizadeh M, Mir M. Low-level laser therapy and 18yo-fascial pain dysfunction syndrome: a randomized controlled clinical trial. Lasers Med Sci. 2009;24(5):715-20.
45 Leal de Godoy CH, Motta LJ, Santos Fernandes K P, Mesquita-Ferrari RA, Deana AM, Bussadori SK. Effect of low-level laser therapy on adolescents with temporomandibular disorder: a blind randomized controlled pilot study. J Oral Maxillofac Surg. 2015;73(4):622-9.
46 Chan NHY, Ip CK, Li DTS, Leung YY. Diagnosis and treatment of myogenous temporomandibular disorders: a clinical update. Diagnostics (Basel). 2022;12(12):2914.
47 Wu X, Zhu J, Zheng B, Liu J, Wu Z. Effectiveness of low-level gallium aluminium arsenide laser therapy for temporomandibular disorder with myofascial pain: a systemic review and meta-analysis. Medicine (Baltimore). 2021;100(52):e28015.
48 Serrera-Figallo MA, Ruiz-de-León-Hernández G, Torres-Lagares D, Castro-Araya A, Torres-Ferrerosa O, Hernández-Pacheco E, Gutierrez-Perez JL. Use of botulinum toxin in orofacial clinical practice. Toxins (Basel). 2020;12(2):112.
49 Maia ML, Bonjardim LR, Quintans Jde S, Ribeiro MA, Maia LG, Conti PC. Effect of low-level laser therapy on pain levels in patients with temporomandibular disorders: a systematic review. J Appl Oral Sci. 2012;20(6):594-602.
50 Petrucci A, Sgolastra F, Gatto R, Mattei A, Monaco A. Effectiveness of low-level laser therapy in temporomandibular disorders: a systematic review and meta-analysis. J Orofac Pain. 2011;25(4):298-307.
51 Honnef LR, Pauletto P, Conti Réus J, Massignan C, Souza BDM, Michelotti A, Flores-Mir C, De Luca Canto G. Effects of stabilization splints on the signs and symptoms of temporomandibular disorders of muscular origin: A systematic review. Cranio. 2022:1-12.
52 Medlicott MS, Harris SR. A systematic review of the effectiveness of exercise, manual therapy, electrotherapy, relaxation training, and biofeedback in the management of temporomandibular disorder. Phys Ther. 2006;86(7):955-73.
53 Fernández-de-Las-Peñas C, Von Piekartz H. Clinical reasoning for the examination and physical therapy treatment of temporomandibular disorders (TMD): a narrative literature review. J Clin Med. 2020;9(11):3686.
54 Blanco-Rueda JA, López-Valverde A, Márquez-Vera A, Méndez-Sánchez R, López-García E, López-Valverde N. Preliminary findings of the efficacy of botulinum toxin in temporomandibular disorders: uncontrolled pilot study. Life (Basel). 2023;13(2):345.
55 Awan KH, Patil S, Alamir AWH, Maddur N, Arakeri G, Carrozzo M, Brennan PA. Botulinum toxin in the management of myofascial pain associated with temporomandibular dysfunction. J Oral Pathol Med. 2019;48(3):192-200.
56 Kütük SG, Özkan Y, Kütük M, Özdaş T. Comparison of the efficacies of dry needling and botox methods in the treatment of myofascial pain syndrome affecting the temporomandibular joint. J Craniofac Surg. 2019;30(5):1556-9.
57 Schwartz M, Freund B. Treatment of temporomandibular disorders with botulinum toxin. Clin J Pain. 2002;18(6 Suppl):S198-203.
58 Kang SK, Lee YH, Park H, Ro JY, Auh QS. Effects of intramuscular morphine in men and women with temporomandibular disorder with myofascial pain. Oral Dis. 2018;24(8):1591-8.
59 Häggman-Henrikson B, Alstergren P, Davidson T, Högestätt ED, Östlund P, Tranaeus S, Vitols S, List T. Pharmacological treatment of oro-facial pain - health technology assessment including a systematic review with network meta-analysis. J Oral Rehabil. 2017;44(10):800-26.
60 Vier C, Almeida MB, Neves ML, Santos ARSD, Bracht MA. The effectiveness of dry needling for patients with orofacial pain associated with temporomandibular dysfunction: a systematic review and meta-analysis. Braz J Phys Ther. 2019;23(1):3-11.
61 Sirikaku K, Watinaga GK, de Souza Moraes S, Guimarães TB, Onishi ET. Effect of dry needling on the masseter muscle in the tinnitus perception of patients with temporomandibular disorder. J Maxillofac Oral Surg. 2023;22(3):571-8.
62 Okeson JP, de Kanter RJ. Temporomandibular disorders in the medical practice. J Fam Pract. 1996;43(4):347-56.
Submetido em:
06/11/2023
Aceito em:
22/03/2024
Facebook
Google+
Twitter
LinkedIn
Mendeley
Email